Biofunctionalization of β-cyclodextrin nanosponges using cholesterol.

Area of Science:

• Biomaterials Science
• Nanotechnology
• Drug Delivery Systems

Background:

• Cyclodextrins nanosponges (CD-NSPs) are porous polymers for therapeutic agent delivery.
• Their limited cellular binding restricts drug delivery applications.
• Cholesterol is an endogenous molecule crucial for cell interactions.

Purpose of the Study:

• To functionalize β-cyclodextrin nanosponges (β-CD-NSP) with cholesterol.
• To enhance the cellular binding and uptake of CD-NSPs for drug delivery.
• To evaluate the drug adsorption and cellular uptake of the modified nanosponges.

Main Methods:

• Surface functionalization of β-CD-NSP with cholesterol.
• Characterization using spectroscopic, microscopic, and thermogravimetric techniques.
• Cytotoxicity assay and doxorubicin adsorption studies.
• Confocal laser scanning microscopy (CLSM) for cellular uptake analysis.

Main Results:

• Successful grafting of cholesterol onto β-CD-NSP confirmed.
• Synthesized β-CD-NSP demonstrated safety in cytotoxicity assays.
• Enhanced cellular uptake of cholesterol-modified β-CD-NSP was observed.
• Doxorubicin adsorption onto the modified nanosponges was evaluated.

Conclusions:

• Cholesterol modification significantly improves β-CD-NSP cellular uptake.
• The cholesterol-grafted β-CD-NSP system is a promising candidate for site-specific drug delivery.
• This approach overcomes the limitations of native CD-NSPs in cellular interactions.